OpenURL Connection Search

Select item for more details and to access through your institution.

Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25418-5
By:
- Homma, Tomoyuki;
- Nagata, Noriyo;
- Hashimoto, Masayuki;
- Iwata-Yoshikawa, Naoko;
- Seki, Naomi M.;
- Shiwa-Sudo, Nozomi;
- Ainai, Akira;
- Dohi, Keiji;
- Nikaido, Eiji;
- Mukai, Akiko;
- Ukai, Yuuta;
- Nakagawa, Takayuki;
- Shimo, Yusuke;
- Maeda, Hiroki;
- Shirai, Seiki;
- Aoki, Miwa;
- Sonoyama, Takuhiro;
- Sato, Mamoru;
- Fumoto, Masataka;
- Nagira, Morio
Publication type:
Article
Destruxin E Decreases Beta-Amyloid Generation by Reducing Colocalization of Beta-Amyloid-Cleaving Enzyme 1 and Beta-Amyloid Protein Precursor.
Published in:
Neurodegenerative Diseases, 2010, v. 6, n. 5/6, p. 230, doi. 10.1159/000236902
By:
- Itoh, Naohiro;
- Okochi, Masayasu;
- Tagami, Shinji;
- Nishitomi, Kouhei;
- Nakayama, Taisuke;
- Yanagida, Kanta;
- Fukumori, Akio;
- Jiang, Jingwei;
- Mori, Kohji;
- Hosono, Motoko;
- Kikuchi, Jyunko;
- Nakano, Yuko;
- Takinami, Yoshihiko;
- Dohi, Keiji;
- Nishigaki, Atsuko;
- Takemoto, Hiroshi;
- Minagawa, Kazuyuki;
- Katoh, Takaaki;
- Willem, Michael;
- Haass, Christian
Publication type:
Article
Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively.
Published in:
Scientific Reports, 2015, p. 8042, doi. 10.1038/srep08042
By:
- Shojima, Kensaku;
- Sato, Akira;
- Hanaki, Hideaki;
- Tsujimoto, Ikuko;
- Nakamura, Masahiro;
- Hattori, Kazunari;
- Sato, Yuji;
- Dohi, Keiji;
- Hirata, Michinari;
- Yamamoto, Hideki;
- Kikuchi, Akira
Publication type:
Article
S-222611, an oral reversible tyrosine kinase inhibitor of EGFR and HER2. A representative histological image of the colon treated with S-222611 (25 mg/kg).
Published in:
2014
By:
- Tanaka, Hidekazu;
- Hirata, Michinari;
- Shinonome, Satomi;
- Wada, Toru;
- Iguchi, Motofumi;
- Dohi, Keiji;
- Inoue, Makiko;
- Ishioka, Yukichi;
- Hojo, Kanji;
- Yamada, Tomomi;
- Sugimoto, Tatsuya;
- Masuno, Koichi;
- Nezasa, Ken‐ichi;
- Sato, Norihito;
- Matsuo, Kenji;
- Yonezawa, Shuji;
- Frenkel, Eugene P.;
- Shichijo, Michitaka
Publication type:
Other
Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2.
Published in:
Cancer Science, 2014, v. 105, n. 8, p. 1040, doi. 10.1111/cas.12449
By:
- Tanaka, Hidekazu;
- Hirata, Michinari;
- Shinonome, Satomi;
- Wada, Toru;
- Iguchi, Motofumi;
- Dohi, Keiji;
- Inoue, Makiko;
- Ishioka, Yukichi;
- Hojo, Kanji;
- Yamada, Tomomi;
- Sugimoto, Tatsuya;
- Masuno, Koichi;
- Nezasa, Ken‐ichi;
- Sato, Norihito;
- Matsuo, Kenji;
- Yonezawa, Shuji;
- Frenkel, Eugene P.;
- Shichijo, Michitaka
Publication type:
Article
Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Published in:
2024
By:
- Homma, Tomoyuki;
- Nagata, Noriyo;
- Hashimoto, Masayuki;
- Iwata-Yoshikawa, Naoko;
- Seki, Naomi M.;
- Shiwa-Sudo, Nozomi;
- Ainai, Akira;
- Dohi, Keiji;
- Nikaido, Eiji;
- Mukai, Akiko;
- Ukai, Yuuta;
- Nakagawa, Takayuki;
- Shimo, Yusuke;
- Maeda, Hiroki;
- Shirai, Seiki;
- Aoki, Miwa;
- Sonoyama, Takuhiro;
- Sato, Mamoru;
- Fumoto, Masataka;
- Nagira, Morio
Publication type:
Correction Notice

Found: 6

Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.

Destruxin E Decreases Beta-Amyloid Generation by Reducing Colocalization of Beta-Amyloid-Cleaving Enzyme 1 and Beta-Amyloid Protein Precursor.

Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively.

S-222611, an oral reversible tyrosine kinase inhibitor of EGFR and HER2. A representative histological image of the colon treated with S-222611 (25 mg/kg).

Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2.

Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.